From The Innovator’s Workbench featuring Anne Wojcicki : CEO of 23andMe

April 13, 2022

Anne Wojcicki launched 23andMe to empower people by helping them access, understand and benefit from their own genetic information. The company produces a portfolio of tools that provide personalized insights on genetic health risk for a range of conditions and is developing new medicines including cancer therapies validated by human genetics.  In a one-on-one conversation with David Cassak, co-editor in chief of Medtech Strategist, Wojcicki will share stories from the front lines of innovation as her pioneer DNA testing firm seeks to address serious unmet medical needs and drive forward a better and more inclusive world.

Register here: